Phelps AL - Search Results

1

Aerosol infection of Balb/c mice with eastern equine encephalitis virus; susceptibility and lethality.

Phelps AL, O'Brien LM, Eastaugh LS, Davies C, Lever MS, Ennis J, Zeitlin L, Nunez A, Ulaeto DO. Phelps AL, et al. Virol J. 2019 Jan 5;16(1):2. doi: 10.1186/s12985-018-1103-7. Virol J. 2019. PMID: 30611287 Free PMC article.

2

Comparative efficacy of replicating smallpox vaccine strains in a murine challenge model.

Phelps A, Gates AJ, Hillier M, Eastaugh L, Ulaeto DO. Phelps A, et al. Vaccine. 2005 May 20;23(27):3500-7. doi: 10.1016/j.vaccine.2005.02.005. Vaccine. 2005. PMID: 15855008

3

Comparative efficacy of modified vaccinia Ankara (MVA) as a potential replacement smallpox vaccine.

Phelps AL, Gates AJ, Hillier M, Eastaugh L, Ulaeto DO. Phelps AL, et al. Vaccine. 2007 Jan 2;25(1):34-42. doi: 10.1016/j.vaccine.2006.07.022. Epub 2006 Aug 1. Vaccine. 2007. PMID: 16950548

4

Alpha interferon as an adenovirus-vectored vaccine adjuvant and antiviral in Venezuelan equine encephalitis virus infection.

O'Brien L, Perkins S, Williams A, Eastaugh L, Phelps A, Wu J, Phillpotts R. O'Brien L, et al. J Gen Virol. 2009 Apr;90(Pt 4):874-882. doi: 10.1099/vir.0.006833-0. Epub 2009 Mar 4. J Gen Virol. 2009. PMID: 19264673

5

Development of a novel monoclonal antibody with reactivity to a wide range of Venezuelan equine encephalitis virus strains.

O'Brien LM, Underwood-Fowler CD, Goodchild SA, Phelps AL, Phillpotts RJ. O'Brien LM, et al. Among authors: phelps al. Virol J. 2009 Nov 19;6:206. doi: 10.1186/1743-422X-6-206. Virol J. 2009. PMID: 19925641 Free PMC article.

6

A recombinant humanized monoclonal antibody completely protects mice against lethal challenge with Venezuelan equine encephalitis virus.

Hu WG, Phelps AL, Jager S, Chau D, Hu CC, O'Brien LM, Perkins SD, Gates AJ, Phillpotts RJ, Nagata LP. Hu WG, et al. Among authors: phelps al. Vaccine. 2010 Aug 2;28(34):5558-64. doi: 10.1016/j.vaccine.2010.06.038. Epub 2010 Jun 25. Vaccine. 2010. PMID: 20600509

7

Assessment of antimicrobial peptide LL-37 as a post-exposure therapy to protect against respiratory tularemia in mice.

Flick-Smith HC, Fox MA, Hamblin KA, Richards MI, Jenner DC, Laws TR, Phelps AL, Taylor C, Harding SV, Ulaeto DO, Atkins HS. Flick-Smith HC, et al. Among authors: phelps al. Peptides. 2013 May;43:96-101. doi: 10.1016/j.peptides.2013.02.024. Epub 2013 Mar 14. Peptides. 2013. PMID: 23500517

8

Buffer AVL Alone Does Not Inactivate Ebola Virus in a Representative Clinical Sample Type.

Smither SJ, Weller SA, Phelps A, Eastaugh L, Ngugi S, O'Brien LM, Steward J, Lonsdale SG, Lever MS. Smither SJ, et al. J Clin Microbiol. 2015 Oct;53(10):3148-54. doi: 10.1128/JCM.01449-15. Epub 2015 Jul 15. J Clin Microbiol. 2015. PMID: 26179307 Free PMC article.

9

Effectiveness of Four Disinfectants against Ebola Virus on Different Materials.

Smither S, Phelps A, Eastaugh L, Ngugi S, O'Brien L, Dutch A, Lever MS. Smither S, et al. Viruses. 2016 Jul 7;8(7):185. doi: 10.3390/v8070185. Viruses. 2016. PMID: 27399759 Free PMC article.

10

Ebola Virus Makona Shows Reduced Lethality in an Immune-deficient Mouse Model.

Smither SJ, Eastaugh L, Ngugi S, O'Brien L, Phelps A, Steward J, Lever MS. Smither SJ, et al. J Infect Dis. 2016 Oct 15;214(suppl 3):S268-S274. doi: 10.1093/infdis/jiw145. Epub 2016 Jul 28. J Infect Dis. 2016. PMID: 27471321

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

73 results

Search Page

Filters